FIVE PRIME THERAPEUTICS INC 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Sep 24, 2013
Insider Transaction Report
Form 4
Douglas R Lee
Director
Transactions
- Conversion
Commom Stock
2013-09-23+4,065→ 4,065 total(indirect: By Trust) - Conversion
Commom Stock
2013-09-23+119→ 4,184 total(indirect: By Trust) - Conversion
Series A-2 Preferred Stock
2013-09-23−119→ 0 total(indirect: By Trust)→ Common Stock (119 underlying) - Conversion
Series A Preferred Stock
2013-09-23−4,065→ 0 total(indirect: By Trust)→ Common Stock (4,065 underlying)
Holdings
- 27,100
Common Stock
Footnotes (1)
- [F1]Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted into one share of common stock. The convertible preferred stock had no expiration date.